734150006: Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide 10 milligram/1 each conventional release oral tablet (clinical drug)

SNOMED CT Concept\produit pharmaceutique ou biologique\Medicinal product (product)\...

\Medicinal product categorized by disposition (product)\inhibiteur enzymatique\...

\Cytochrome P450 inhibitor-containing product\Product containing cobicistat (medicinal product)\...

\Product containing cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Product containing cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet

\Cobicistat-containing product in oral dose form\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet

\Product containing transferase inhibitor (product)\Product containing nucleotidyltransferase inhibitor (product)\Product containing integrase strand transfer inhibitor (product)\Product containing elvitegravir (medicinal product)\Product containing cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Product containing transferase inhibitor (product)\Product containing nucleotidyltransferase inhibitor (product)\Product containing integrase strand transfer inhibitor (product)\Product containing elvitegravir (medicinal product)\Product containing cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Product containing transferase inhibitor (product)\Product containing nucleotidyltransferase inhibitor (product)\Product containing integrase strand transfer inhibitor (product)\Product containing elvitegravir (medicinal product)\Elvitegravir-containing product in oral dose form\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Product containing transferase inhibitor (product)\Product containing reverse transcriptase inhibitor (product)\Product containing emtricitabine (medicinal product)\Emtricitabine-containing product in oral dose form\Product containing emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Product containing transferase inhibitor (product)\Product containing reverse transcriptase inhibitor (product)\Product containing emtricitabine (medicinal product)\Product containing emtricitabine and tenofovir (medicinal product)\Product containing cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Product containing transferase inhibitor (product)\Product containing reverse transcriptase inhibitor (product)\Product containing emtricitabine (medicinal product)\Product containing emtricitabine and tenofovir (medicinal product)\Product containing cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Product containing transferase inhibitor (product)\Product containing reverse transcriptase inhibitor (product)\Product containing emtricitabine (medicinal product)\Product containing emtricitabine and tenofovir (medicinal product)\Product containing emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Product containing transferase inhibitor (product)\Product containing reverse transcriptase inhibitor (product)\Product containing tenofovir (medicinal product)\Product containing tenofovir in oral dose form (medicinal product form)\Product containing emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Product containing transferase inhibitor (product)\Product containing reverse transcriptase inhibitor (product)\Product containing tenofovir (medicinal product)\Product containing emtricitabine and tenofovir (medicinal product)\Product containing cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Product containing transferase inhibitor (product)\Product containing reverse transcriptase inhibitor (product)\Product containing tenofovir (medicinal product)\Product containing emtricitabine and tenofovir (medicinal product)\Product containing cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Product containing transferase inhibitor (product)\Product containing reverse transcriptase inhibitor (product)\Product containing tenofovir (medicinal product)\Product containing emtricitabine and tenofovir (medicinal product)\Product containing emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet

\Medicinal product categorized by structure\Ether structure-containing product\Product containing elvitegravir (medicinal product)\Product containing cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Medicinal product categorized by structure\Ether structure-containing product\Product containing elvitegravir (medicinal product)\Product containing cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Medicinal product categorized by structure\Ether structure-containing product\Product containing elvitegravir (medicinal product)\Elvitegravir-containing product in oral dose form\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Medicinal product categorized by structure\Product containing organic acid and/or organic acid derivative (product)\Carboxylic acid and/or carboxylic acid derivative-containing product\Product containing carbamate (product)\Product containing cobicistat (medicinal product)\Product containing cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Medicinal product categorized by structure\Product containing organic acid and/or organic acid derivative (product)\Carboxylic acid and/or carboxylic acid derivative-containing product\Product containing carbamate (product)\Product containing cobicistat (medicinal product)\Product containing cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Medicinal product categorized by structure\Product containing organic acid and/or organic acid derivative (product)\Carboxylic acid and/or carboxylic acid derivative-containing product\Product containing carbamate (product)\Product containing cobicistat (medicinal product)\Cobicistat-containing product in oral dose form\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Medicinal product categorized by structure\Product containing organic acid and/or organic acid derivative (product)\Carboxylic acid and/or carboxylic acid derivative-containing product\Product containing tenofovir (medicinal product)\Product containing tenofovir in oral dose form (medicinal product form)\Product containing emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Medicinal product categorized by structure\Product containing organic acid and/or organic acid derivative (product)\Carboxylic acid and/or carboxylic acid derivative-containing product\Product containing tenofovir (medicinal product)\Product containing emtricitabine and tenofovir (medicinal product)\Product containing cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Medicinal product categorized by structure\Product containing organic acid and/or organic acid derivative (product)\Carboxylic acid and/or carboxylic acid derivative-containing product\Product containing tenofovir (medicinal product)\Product containing emtricitabine and tenofovir (medicinal product)\Product containing cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Medicinal product categorized by structure\Product containing organic acid and/or organic acid derivative (product)\Carboxylic acid and/or carboxylic acid derivative-containing product\Product containing tenofovir (medicinal product)\Product containing emtricitabine and tenofovir (medicinal product)\Product containing emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Medicinal product categorized by structure\Urea and/or urea derivative-containing product\Product containing cobicistat (medicinal product)\Product containing cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Medicinal product categorized by structure\Urea and/or urea derivative-containing product\Product containing cobicistat (medicinal product)\Product containing cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Medicinal product categorized by structure\Urea and/or urea derivative-containing product\Product containing cobicistat (medicinal product)\Cobicistat-containing product in oral dose form\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Medicinal product categorized by structure\Chlorine and/or chlorine compound-containing product\Product containing chlorinated hydrocarbon (product)\Product containing elvitegravir (medicinal product)\Product containing cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Medicinal product categorized by structure\Chlorine and/or chlorine compound-containing product\Product containing chlorinated hydrocarbon (product)\Product containing elvitegravir (medicinal product)\Product containing cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Medicinal product categorized by structure\Chlorine and/or chlorine compound-containing product\Product containing chlorinated hydrocarbon (product)\Product containing elvitegravir (medicinal product)\Elvitegravir-containing product in oral dose form\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing pyrimidine (product)\Product containing emtricitabine (medicinal product)\Emtricitabine-containing product in oral dose form\Product containing emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing pyrimidine (product)\Product containing emtricitabine (medicinal product)\Product containing emtricitabine and tenofovir (medicinal product)\Product containing cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing pyrimidine (product)\Product containing emtricitabine (medicinal product)\Product containing emtricitabine and tenofovir (medicinal product)\Product containing cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing pyrimidine (product)\Product containing emtricitabine (medicinal product)\Product containing emtricitabine and tenofovir (medicinal product)\Product containing emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing quinoline (product)\Product containing elvitegravir (medicinal product)\Product containing cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing quinoline (product)\Product containing elvitegravir (medicinal product)\Product containing cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing quinoline (product)\Product containing elvitegravir (medicinal product)\Elvitegravir-containing product in oral dose form\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Medicinal product categorized by structure\Product containing halogenated hydrocarbon (product)\Product containing chlorinated hydrocarbon (product)\Product containing elvitegravir (medicinal product)\Product containing cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Medicinal product categorized by structure\Product containing halogenated hydrocarbon (product)\Product containing chlorinated hydrocarbon (product)\Product containing elvitegravir (medicinal product)\Product containing cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Medicinal product categorized by structure\Product containing halogenated hydrocarbon (product)\Product containing chlorinated hydrocarbon (product)\Product containing elvitegravir (medicinal product)\Elvitegravir-containing product in oral dose form\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Medicinal product categorized by structure\Product containing sulfur and/or sulfur compound (product)\Product containing thiazole (product)\Product containing cobicistat (medicinal product)\Product containing cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Medicinal product categorized by structure\Product containing sulfur and/or sulfur compound (product)\Product containing thiazole (product)\Product containing cobicistat (medicinal product)\Product containing cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Medicinal product categorized by structure\Product containing sulfur and/or sulfur compound (product)\Product containing thiazole (product)\Product containing cobicistat (medicinal product)\Cobicistat-containing product in oral dose form\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet

\Medicinal product categorised by therapeutic role\Antiviral agent\Antiretroviral agent\...

\Product containing elvitegravir (medicinal product)\Product containing cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Product containing elvitegravir (medicinal product)\Product containing cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Product containing elvitegravir (medicinal product)\Elvitegravir-containing product in oral dose form\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet

\Product containing emtricitabine (medicinal product)\Emtricitabine-containing product in oral dose form\Product containing emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Product containing emtricitabine (medicinal product)\Product containing emtricitabine and tenofovir (medicinal product)\Product containing cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Product containing emtricitabine (medicinal product)\Product containing emtricitabine and tenofovir (medicinal product)\Product containing cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Product containing emtricitabine (medicinal product)\Product containing emtricitabine and tenofovir (medicinal product)\Product containing emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet

\Product containing tenofovir (medicinal product)\Product containing tenofovir in oral dose form (medicinal product form)\Product containing emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Product containing tenofovir (medicinal product)\Product containing emtricitabine and tenofovir (medicinal product)\Product containing cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Product containing tenofovir (medicinal product)\Product containing emtricitabine and tenofovir (medicinal product)\Product containing cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Product containing tenofovir (medicinal product)\Product containing emtricitabine and tenofovir (medicinal product)\Product containing emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet

\Product manufactured as oral dose form (product)\Emtricitabine-containing product in oral dose form\Product containing emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Product manufactured as oral dose form (product)\Elvitegravir-containing product in oral dose form\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Product manufactured as oral dose form (product)\Cobicistat-containing product in oral dose form\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet
\Product manufactured as oral dose form (product)\Product containing tenofovir in oral dose form (medicinal product form)\Product containing emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2017. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3487411011 Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3677808015 Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide 10 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	est un(e) (attribut)	Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)	true	Inferred relationship	Some
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Plays role	Antiretroviral therapeutic role	true	Inferred relationship	Some
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has basis of strength substance (attribute)	Cobicistat	true	Inferred relationship	Some	3
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has basis of strength substance (attribute)	Emtricitabine (substance)	true	Inferred relationship	Some	1
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has precise active ingredient	Emtricitabine (substance)	true	Inferred relationship	Some	1
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has precise active ingredient	Cobicistat	true	Inferred relationship	Some	3
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	est un(e) (attribut)	Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form	false	Inferred relationship	Some
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	a une forme pharmaceutique (attribut)	Oral tablet	true	Inferred relationship	Some
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has presentation strength numerator unit	milligram (qualifier value)	false	Inferred relationship	Some	5
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has presentation strength denominator value	un	false	Inferred relationship	Some	5
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has presentation strength denominator unit (attribute)	Tablet (unit of presentation)	false	Inferred relationship	Some	5
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has presentation strength numerator unit	milligram (qualifier value)	false	Inferred relationship	Some	6
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has presentation strength denominator value	un	false	Inferred relationship	Some	6
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has presentation strength denominator unit (attribute)	Tablet (unit of presentation)	false	Inferred relationship	Some	6
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has presentation strength numerator unit	milligram (qualifier value)	false	Inferred relationship	Some	7
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has presentation strength denominator value	un	false	Inferred relationship	Some	7
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has presentation strength denominator unit (attribute)	Tablet (unit of presentation)	false	Inferred relationship	Some	7
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	a pour principe actif (attribut)	Cobicistat	false	Inferred relationship	Some	8
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has basis of strength substance (attribute)	Cobicistat	false	Inferred relationship	Some	8
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has presentation strength numerator value (attribute)	150 (qualifier value)	false	Inferred relationship	Some	8
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has presentation strength numerator unit	milligram (qualifier value)	false	Inferred relationship	Some	8
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has presentation strength denominator value	un	false	Inferred relationship	Some	8
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has presentation strength denominator unit (attribute)	Tablet (unit of presentation)	false	Inferred relationship	Some	8
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	a pour principe actif (attribut)	Elvitegravir (substance)	false	Inferred relationship	Some	6
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has basis of strength substance (attribute)	Elvitegravir (substance)	false	Inferred relationship	Some	6
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has presentation strength numerator value (attribute)	150 (qualifier value)	false	Inferred relationship	Some	6
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	a pour principe actif (attribut)	Emtricitabine (substance)	false	Inferred relationship	Some	7
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has basis of strength substance (attribute)	Emtricitabine (substance)	false	Inferred relationship	Some	7
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has presentation strength numerator value (attribute)	200 (qualifier value)	false	Inferred relationship	Some	7
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	a pour principe actif (attribut)	ténofovir alafénamide	false	Inferred relationship	Some	5
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has basis of strength substance (attribute)	ténofovir alafénamide	false	Inferred relationship	Some	5
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has presentation strength numerator value (attribute)	dix	false	Inferred relationship	Some	5
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has unit of presentation	Tablet (unit of presentation)	true	Inferred relationship	Some
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has presentation strength denominator value	un	false	Inferred relationship	Some	1
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has presentation strength denominator unit (attribute)	Tablet (unit of presentation)	true	Inferred relationship	Some	2
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has presentation strength numerator unit	milligram (qualifier value)	true	Inferred relationship	Some	4
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has presentation strength numerator value (attribute)	150 (qualifier value)	false	Inferred relationship	Some	2
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has presentation strength denominator value	un	false	Inferred relationship	Some	3
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has presentation strength numerator unit	milligram (qualifier value)	true	Inferred relationship	Some	3
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has presentation strength numerator unit	milligram (qualifier value)	true	Inferred relationship	Some	2
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has presentation strength numerator unit	milligram (qualifier value)	true	Inferred relationship	Some	1
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has presentation strength denominator value	un	false	Inferred relationship	Some	4
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has presentation strength denominator unit (attribute)	Tablet (unit of presentation)	true	Inferred relationship	Some	3
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has presentation strength denominator unit (attribute)	Tablet (unit of presentation)	true	Inferred relationship	Some	1
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has presentation strength numerator value (attribute)	150 (qualifier value)	false	Inferred relationship	Some	1
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has presentation strength denominator unit (attribute)	Tablet (unit of presentation)	true	Inferred relationship	Some	4
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has presentation strength denominator value	un	false	Inferred relationship	Some	2
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has basis of strength substance (attribute)	Cobicistat	false	Inferred relationship	Some	1
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has precise active ingredient	Cobicistat	false	Inferred relationship	Some	1
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has basis of strength substance (attribute)	Emtricitabine (substance)	false	Inferred relationship	Some	3
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has presentation strength numerator value (attribute)	200 (qualifier value)	false	Inferred relationship	Some	3
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has precise active ingredient	Elvitegravir (substance)	true	Inferred relationship	Some	2
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has basis of strength substance (attribute)	Elvitegravir (substance)	true	Inferred relationship	Some	2
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has precise active ingredient	Emtricitabine (substance)	false	Inferred relationship	Some	3
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has presentation strength numerator value (attribute)	dix	false	Inferred relationship	Some	4
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has precise active ingredient	ténofovir alafénamide	true	Inferred relationship	Some	4
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has basis of strength substance (attribute)	ténofovir alafénamide	true	Inferred relationship	Some	4
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Count of base of active ingredient	quatre	false	Inferred relationship	Some

Inbound Relationships

Type

Active

Source

Characteristic

Refinability

Group

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3487411011	Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3677808015	Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide 10 milligram/1 each conventional release oral tablet (clinical drug)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core